Beta Bionics (BBNX) Asset Utilization Ratio (2025 - 2026)
Beta Bionics recorded quarterly Asset Utilization Ratio of 0.35 in Q1 2026, up 14.41% quarter-over-quarter from 0.3 in Q4 2025, and up 21.59% year-over-year from 0.29 in Q1 2025.
Beta Bionics' Asset Utilization Ratio history runs 2 years deep, the most recent figure standing at 0.35 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio rose 21.59% year-over-year to 0.35; the TTM figure through Mar 2026 stood at 0.35 (up 21.59% YoY), while the FY2025 annual figure was 0.42, down 16.44% from the prior year.
- Asset Utilization Ratio came in at 0.35 for Q1 2026 at Beta Bionics, up from 0.3 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.35 in Q1 2026 to a low of 0.23 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.46 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.54 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.39 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.47 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.47 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.65 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.74 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.57 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.56 |
| 10 | Beta Bionics | 572.34 Mn | 542.03 Mn | 16.44 Mn | 0.35 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.35 |
| Dec 31, 2025 | 0.30 |
| Sep 30, 2025 | 0.27 |
| Jun 30, 2025 | 0.23 |
| Mar 31, 2025 | 0.29 |